- Home
- SBLK vs CLDX Comparison
SBLK vs CLDX Comparison
Compare SBLK & CLDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SBLK | CLDX |
|---|---|---|
| Founded | 2006 | N/A |
| Country | Greece | United States |
| Employees | N/A | N/A |
| Industry | Marine Transportation | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.9B | 2.4B |
| IPO Year | 2007 | 1995 |
Fundamental Metrics
Financial Performance| Metric | SBLK | CLDX |
|---|---|---|
| Price | $26.85 | $32.58 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 10 |
| Target Price | $25.50 | ★ $46.60 |
| AVG Volume (30 Days) | ★ 1.3M | 705.6K |
| Earning Date | 05-20-2026 | 05-04-2026 |
| Dividend Yield | ★ 2.33% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $12,743,000.00 |
| Revenue This Year | $11.56 | $111.39 |
| Revenue Next Year | N/A | $235.85 |
| P/E Ratio | $47.06 | ★ N/A |
| Revenue Growth | N/A | ★ 87.78 |
| 52 Week Low | $16.22 | $19.52 |
| 52 Week High | $28.50 | $35.83 |
Technical Indicators
Market Signals| Indicator | SBLK | CLDX |
|---|---|---|
| Relative Strength Index (RSI) | 51.65 | 60.38 |
| Support Level | $26.06 | $28.51 |
| Resistance Level | $27.45 | $35.10 |
| Average True Range (ATR) | 0.70 | 1.12 |
| MACD | -0.13 | 0.41 |
| Stochastic Oscillator | 27.95 | 84.06 |
Price Performance
Historical ComparisonAbout SBLK Star Bulk Carriers Corp.
Star Bulk Carriers Corp provides seaborne transportation solutions in the dry bulk sector. The company owns and operates dry bulk carrier vessels, which are used to transport bulk, such as iron ore, coal, grains, bauxite, fertilizers, and steel products. It owns a fleet of vessels that consists of Newcastlemax, Capesize, Post Panamax, Kamsarmax, Panamax, Ultramax, and Supramax. The firm generates the majority of its revenue from Time charters and Voyage charters.
About CLDX Celldex Therapeutics Inc.
Celldex Therapeutics Inc is a biopharmaceutical firm focused on mast cell biology and the development of therapeutic antibodies. Its pipeline includes monoclonal and bispecific antibodies aimed at treating severe inflammatory, allergic, autoimmune, and other mast cell-mediated diseases. The company operates in a single operating and reportable segment in the business of development, manufacturing and commercialization of novel therapeutics for human health care.